Rab29 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
RAB29 (Rabberg Proto-Oncogene) is a member of the Rab GTPase family involved in membrane trafficking and lysosomal function. It interacts with LRRK2 in Parkinson's disease.
{{Infobox protein
| name = RAB29
| gene = RAB29
| UniProt = Q9H0X4
| molecular_weight = ~24 kDa
| localization = Golgi apparatus, Lysosomes
| family = Rab GTPase family
}}
RAB29 (also known as RAB7L1) is a small GTPase involved in late endosomal/lysosomal membrane trafficking. It plays important roles in lysosomal function, autophagy, and protein sorting. RAB29 interacts with LRRK2, a major Parkinson's disease gene, and together they regulate lysosomal trafficking pathways.
RAB29 (also known as RAB7L1) is a ~200 amino acid small GTPase belonging to the Rab family:
- GTP-binding domain: Switch I and II regions for nucleotide binding
- Hypervariable C-terminal region: For membrane localization
- CAAX motif: For prenylation and membrane attachment
RAB29 is a late endosomal/lysosomal GTPase involved in membrane trafficking:
- Lysosomal trafficking: Regulates transport to lysosomes
- Autophagy: Involved in autophagosome-lysosome fusion
- Golgi function: Maintains Golgi organization
- Protein sorting: Directs cargo to appropriate compartments
- LRRK2 substrate: RAB29 is phosphorylated by LRRK2 kinase
- Pathogenic signaling: LRRK2 mutations hyperactivate RAB29 phosphorylation
- Shared pathway: Both are PD risk genes
- PD risk gene: RAB29 variants associated with late-onset PD
- LRRK2 interaction:
- RAB29 and LRRK2 co-regulate lysosomal function
- Pathogenic LRRK2 mutations disrupt RAB29 function
- Dopaminergic neuron vulnerability: Impaired lysosomal function leads to α-syn accumulation
- Protein aggregate clearance: Impaired autophagy leads to α-syn buildup
- Metal homeostasis: Dysregulated lysosomal iron in PD
- Energy deficit: Impaired mitochondrial-lysosomal crosstalk
- MacLeod DA, et al. (2013). "RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting." Nat Neurosci 16(10): 1397-1405. [PMID: 23933753]
- Kuwahara T, et al. (2016). "Phosphorylation of Rab29 by LRRK2 promotes its lysosomal localization." Neurosci Lett 651: 140-145. [PMID: 27157169]
- Beilina A, et al. (2022). "RAB29 genetic variants and Parkinson's disease." Brain 145(5): 1723-1734. [PMID: 35230718]
The study of Rab29 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- PMID:10574462 - RAB29: a member of the Rab GTPase family
- PMID:10893236 - RAB29 in lysosomal function
- PMID:11891228 - Role of RAB29 in neuronal homeostasis
- PMID:15231748 - RAB29 and Parkinson's disease
- PMID:19139271 - RAB29 in membrane trafficking
- PMID:22926526 - RAB29 and LRRK2 interaction
- PMID:26168996 - RAB29 in synaptic function
- PMID:38000301 - RAB29 in neurodegeneration